Pretreatment with Tocilizumab Prior to the CD3 Bispecific Cevostamab in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Showed a Marked Reduction in Cytokine Release Syndrome Incidence and Severity
| Autor: | Trudel, Suzanne, Bahlis, Nizar J., Spencer, Andrew, Kaedbey, Rayan, Rodriguez Otero, Paula *, Harrison, Simon J, Wong, Chihunt *, Goodman, Grant R., Nakamura, Rin *, Choeurng, Voleak *, Cooper, James *, Mateos, Maria-Victoria |
|---|---|
| Zdroj: | In Blood 15 November 2022 140 Supplement 1:1363-1365 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|